Methods and Strategies for Chemical Synthesis
化学合成的方法和策略
基本信息
- 批准号:9900032
- 负责人:
- 金额:$ 52.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-04-01 至 2024-03-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAlkenesCatalysisComplexCouplingCyclobutanesDevelopmentDrug IndustryElectronsGoalsIn SituMethodsModernizationMolecularNatureNitrogenOrganic ChemistryOutcomePharmacologic SubstanceProcessReactionReagentResearchStructureSystemWorkbasechemical synthesiscycloadditiondrug candidatedrug discoveryimprovedinterestinventionnoveloperationprogramspropadiene
项目摘要
Project Summary/Abstract:
The invention of new methods to access chiral organic molecules is a critical objective in modern organic
chemistry as it is essential for the efficient synthesis of pharmaceutical agents. This is especially relevant as
the pharmaceutical industry is making efforts to increase the 3D complexity of drug candidates. Despite
substantial progress in the field of stereoselective chemical synthesis, many structures remain challenging to
prepare in useful quantities. Therefore, development of new methods and strategies for the chemical
synthesis of stereochemically and topologically complex molecules is of contemporary interest. The long-term
goals of our research program are to introduce general and efficient strategies for the stereoselective synthesis
of difficult-to-access molecular frameworks found in important bioactive molecules. Towards this end, we are
interested in the conversion of abundant and readily available alkenes to more complex structures through
difunctionalization reactions. This approach is attractive because the rapid buildup of complexity can be
achieved as two new bonds and two new stereocenters are generated in a single operation. The studies
described in this application focus on two distinct programs. The first is the development of stereoselective
cross-coupling reactions of Csp3-nucleophiles that are catalytically generated in situ from simple alkenes. Our
rationale for development of these reactions is that widely available alkenes, diboron reagents, and
organohalides are converted to synthetically versatile intermediates. Based on our earlier work, we are
developing Pd/Cu-cooperative catalytic systems for the arylboration of activated alkenes and in particular
demonstrating the functionalization of nitrogen containing heterocycles. In addition, we are developing a
general strategy for unactivated alkene difunctionalization with Ni-catalysis. In the second program of
research, we are developing methods for the enantioselective synthesis of cyclobutanes by [2+2] cycloaddition
of alkenes and electron deficient allenes. Our rationale for the development of these reactions is that due to
the concerted asynchronous nature of these processes, a broad range of alkenes can be utilized. This allows
for the synthesis of a diverse range of stereochemically complex cyclobutanes. The rings generated by these
transformations are directly found in bioactive molecules, can be subjected to a variety of reactions, and
represent novel building blocks for drug discovery. Overall, these studies in reaction development will
introduce new concepts and strategies as well as provide access to new building blocks for chemical synthesis
by exploring new cross-coupling paradigms and cycloaddition reactions.
项目摘要/摘要:
新方法获取手性有机分子的发明是现代有机物的关键目标
化学对于有效合成药物是必不可少的。这特别重要
制药行业正在努力提高候选药物的3D复杂性。尽管
立体选择化学合成领域的实质进展,许多结构仍然具有挑战性
准备有用数量。因此,开发新方法和化学策略
立体和拓扑复杂的分子的合成具有当代利益。长期
我们的研究计划的目标是为立体选择综合介绍一般有效的策略
在重要的生物活性分子中发现的难以访问的分子框架。为此,我们是
对通过大量且随时可用的烯烃转换为更复杂的结构的感兴趣
双功能反应。这种方法很有吸引力,因为复杂性的迅速建立可能是
作为两个新的键和两个新的立体中心的实现,在一次操作中生成。研究
在此应用程序中描述的是两个不同的程序。首先是立体选择性的发展
CSP3-核粉的交叉偶联反应是由简单烯烃原位催化产生的。我们的
这些反应开发的基本原理是广泛可用的烷烃,二迪伯龙试剂和
有机盐转化为合成多功能中间体。根据我们早期的工作,我们是
开发PD/CU合件催化系统,用于活化的烷烃芳基化,尤其是
证明含有杂环的氮的功能化。此外,我们正在开发一个
通过Ni-callysis进行未激活的烯烃进行双官能化的一般策略。在第二个程序中
研究,我们正在开发通过[2+2] Cycloadition的对映选择性合成的对映选择性合成的方法
烯烃和电子缺乏的艾伦。我们对这些反应的发展的理由是
这些过程的一致性异步性,可以利用广泛的烯烃。这允许
为了合成各种立体化学上复杂的循环机构。这些产生的环
转化直接在生物活性分子中发现,可以经过多种反应,并且
代表用于毒品发现的新颖基础。总体而言,这些反应发展的研究将
介绍新的概念和策略,并为化学合成的新构建块提供访问
通过探索新的交叉耦合范例和环加成反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Kevin Brown其他文献
Lessons in Strain and Stability: An Enantioselective Synthesis of (+)-[5]-Ladderanoic Acid.
应变和稳定性的经验教训:( )-[5]-梯烷酸的对映选择性合成。
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
Erin N. Hancock;E. Kuker;D. Tantillo;Michael Kevin Brown - 通讯作者:
Michael Kevin Brown
Michael Kevin Brown的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Kevin Brown', 18)}}的其他基金
Development of New Catalytic Reactions for Chemical Synthesis
化学合成新催化反应的进展
- 批准号:
8861869 - 财政年份:2015
- 资助金额:
$ 52.02万 - 项目类别:
Stereoselective Reactions for the Chemical Synthesis of Bioactive Compounds
生物活性化合物化学合成的立体选择性反应
- 批准号:
8961080 - 财政年份:2015
- 资助金额:
$ 52.02万 - 项目类别:
Stereoselective Reactions for the Chemical Synthesis of Bioactive Compounds
生物活性化合物化学合成的立体选择性反应
- 批准号:
9300975 - 财政年份:2015
- 资助金额:
$ 52.02万 - 项目类别:
Development of New Catalytic Reactions for Chemical Synthesis
化学合成新催化反应的进展
- 批准号:
9231460 - 财政年份:2015
- 资助金额:
$ 52.02万 - 项目类别:
Enatioselective Total Synthesis of Potent Cytotoxic Natural Product Hopeanol
强效细胞毒性天然产物希望醇的对映选择性全合成
- 批准号:
7688100 - 财政年份:2008
- 资助金额:
$ 52.02万 - 项目类别:
Enatioselective Total Synthesis of Potent Cytotoxic Natural Product Hopeanol
强效细胞毒性天然产物希望醇的对映选择性全合成
- 批准号:
7480604 - 财政年份:2008
- 资助金额:
$ 52.02万 - 项目类别:
Enatioselective Total Synthesis of Potent Cytotoxic Natural Product Hopeanol
强效细胞毒性天然产物希望醇的对映选择性全合成
- 批准号:
7923311 - 财政年份:2008
- 资助金额:
$ 52.02万 - 项目类别:
相似国自然基金
构筑碳基Fe3O4-FeCx异质结催化CO2加氢合成烯烃的机制研究
- 批准号:42377249
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
原位固体核磁共振研究烯烃多相氢甲酰化反应动态催化机制
- 批准号:22302192
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
“蜂巢催化”高碳烯烃氢甲酰化反应中的基础问题研究
- 批准号:22372188
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
ZSM-5/铝酸钙酸碱双功能催化剂催化裂解重油制低碳烯烃作用机制及过程强化
- 批准号:22308269
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
核壳型镍催化剂用于原位共聚法制备官能团化聚烯烃复合材料
- 批准号:52373002
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
相似海外基金
Discovering catalytic strategies for transition metal-catalyzed reactions to construct topologically complex organic scaffolds
发现过渡金属催化反应的催化策略以构建拓扑复杂的有机支架
- 批准号:
10714006 - 财政年份:2023
- 资助金额:
$ 52.02万 - 项目类别:
Complementary Activation of Hydroxylamine Derivatives by Hydrogen-Bond Donor Catalysts to Enable Enantioselective Nitrogen-Atom Transfer Processes
通过氢键供体催化剂互补活化羟胺衍生物以实现对映选择性氮原子转移过程
- 批准号:
10404949 - 财政年份:2020
- 资助金额:
$ 52.02万 - 项目类别:
Complementary Activation of Hydroxylamine Derivatives by Hydrogen-Bond Donor Catalysts to Enable Enantioselective Nitrogen-Atom Transfer Processes
通过氢键供体催化剂互补活化羟胺衍生物以实现对映选择性氮原子转移过程
- 批准号:
10176167 - 财政年份:2020
- 资助金额:
$ 52.02万 - 项目类别: